A DFT study on the effect of Au-decoration on the interaction of adrucil drug with BC2N nanotubes in the gas phase and aqueous solution

In-silico optimization of resveratrol interaction with nano-borophene: A DFT-guided study of supramolecular artistry

In this study, the potential of borophene (BOR) as a drug delivery system for resveratrol (RVT) was explored to evaluate its efficacy in cancer treatment. The excited, electronic, and geometric states of RVT, BOR, and the borophene-adsorbed resveratrol complex (BOR@RVT) were calculated to assess BOR's suitability as a drug carrier. Noncovalent interaction (NCI) plots indicated a weak force of attraction between BOR and RVT, which facilitates the offloading of RVT at the target site. Frontier molecular orbital (FMO) analysis showed that during electron excitation from Highest Occupied Molecular Orbital (HOMO) to Lowest Unoccupied Molecular Orbital (LUMO), charge transfer occurs from RVT to BOR. This was further confirmed by charge decomposition analysis (CDA). Calculations for the excited state of BOR@RVT revealed a red shift in the maximum absorption wavelength (λmax), indicating a photoinduced electron transfer (PET) process across various excited states. PET analysis demonstrated fluorescence quenching due to this interaction. Our findings suggest that BOR holds significant potential as a drug delivery vehicle for cancer treatment, offering a promising platform for the development of advanced drug delivery systems.

Synergistic effect of Si-doping and Fe2O3-encapsulation on drug delivery and sensor applications of γ-graphyne nanotube toward favipiravir as an antiviral for COVID-19: A DFT study

In this work, the behavior of favipiravir (FAV) adsorption on the pristine (2,2) graphyne-based γ-nanotube (GYNT) was theoretically studied. Also, the Si-doped form (Si-GYNT) and its composite with encapsulated Fe₂O₃ (Fe₂O₃@Si-GYNT) were investigated within density functional theory (DFT) calculations, using M05 functionals and B3LYP. It was found that FAV is weakly to moderately adsorb on the bare GYNT and Si-GYNT tube, releasing the energy of 2.2 to 19.8 kcal/mol. After FAV adsorption, the bare tube's electronic properties are changed. Localized impurity is induced at the valence and conduction levels by encapsulating a tiny Fe₂O₃ cluster. As such, the target composite becomes a magnetic material. The binding energy between the Fe₂O₃@Si-GYNT and the FAV molecule becomes substantially stronger (E_ad = -25.2 kcal/mol). We developed a drug release system in target parts of body, during protonation in the low pH of injured cells, detaching the FAV from the tube surface. The drug's reaction mechanism with Fe₂O₃@Si-GYNT shifts from covalence in the normal environment to hydrogen bonding in an acidic matrix. The optimized structure's natural bond orbital, quantum molecular descriptors, LUMO, HOMO and energy gap were also investigated. The recovery time can be reduced to less than 10 s by increasing the working temperature properly during the experimental test.